General
In Germany, product safety is primarily governed by the Product Safety Act (PSA or Produktsicherheitsgesetz), which applies whenever products are made available on the market, exhibited on the market or used for the first time in the context of a commercial activity. It also applies to the erection and the operation of installations subject to mandatory inspections, which are used for commercial or economic purposes or which may put employees at risk. With the PSA, Germany has implemented the European Product Safety Directive (2001/95/EC) into German law.
In July 2021, the new Market Surveillance Act (MSA) came into force. With this act, the provisions on market surveillance and installations subject to surveillance were outsourced from the PSA into a separate act. The MSA ensures unified market surveillance in Germany for European harmonised and non-European harmonised non-food products. The conformity of European harmonised non-food products is ensured via the new EU Market Surveillance Regulation. For the first time, the Regulation also governs online trade in the area of market surveillance. From now on, products made available on the market online and offline are to be considered equally within the scope of market surveillance. With the MSA, the relevant provisions from the Regulation for the non-harmonised non-food product sector are transferred into German law. In particular, this concerns products that are only subject to the Directive on General Product Safety (Directive 2001/95/EC). These are, for example, all used consumer products as well as decorative objects, lighters and ladders. Consumer protection rights will thus be significantly strengthened, especially in online trade.
Sector-Specific
Aside from the PSA and MSA, a number of product specific laws and regulations exist, which are based on the respective European directives. Important regulations include the machinery regulation (the ninth regulation to the PSA), the toy safety regulation (the second regulation to the PSA), the law on the electromagnetic compatibility of equipment (Gesetz über die elektromagnetische Verträglichkeit von Betriebsmitteln), the law on medical devices (Gesetz über Medizinprodukte), the medicinal products act (Gesetz über den Verkehr mit Arzneimitteln) and the food and feed code (Lebensmittel-, Bedarfsgegenstände- und Futtermittelgesetzbuch). Many more regulations implementing European law exist for specific types of products. Other laws such as the REACH Regulation, dealing primarily with the registration and admissibility of pharmaceutical products, also have direct relevance for product safety matters.
With the implementation of the new EU Market Surveillance Regulation, the subject is now regulated by the separate Market Surveillance Act (MSA). Thus, the sixth Section (market surveillance) and the seventh Section (information and notification obligations) of the previously applicable PSA are now almost completely transferred to the new MSA.
According to the regulations, the federal states are responsible for market surveillance. Each state is given the competence to determine its own market surveillance authority. Most states have either chosen their government districts (Regierungsbezirke) or trade inspectorates (Gewerbeaufsichtsämter). This means that there is not one main regulator, but rather several regulators that deal with product safety in the territories for which they are responsible. For manufacturers, this means that the local trade inspectorates at the seat of the manufacturer will typically be the relevant regulator.
The German federal states have established a central responsible body, based in Munich, which deals in particular with foreign manufacturers, co-ordinates the work of the local regulators and serves as a central contact point in certain cases.
There are also market surveillance authorities for specific sectors at a federal level, including for example the Federal Motor Transport Authority (Kraftfahrt-Bundesamt), the Federal Network Agency (Bundesnetzagentur) and the Federal Office for Consumer Protection and Food Safety (BVL). For medicinal products and medical products, the Federal Institute for Medicinal Products and Medical Products (BfArM) in Bonn exists as well.
Regulatory Authority Functions
The regulators have four main distinguished functions. First of all, if an authorisation is required before marketing certain products, the specific regulator is competent to issue this authorisation.
Secondly, if a product has been made available to the market, the regulator monitors compliance with product safety requirements. In this function, the regulator will request samples or even purchase samples from the market. Additionally, competitors will often inform the regulator of alleged product safety issues.
Thirdly, if a safety-related issue occurs, the regulator will typically co-ordinate with the producer, its authorised representative or the importer in order to pursue the appropriate remedies, such as a potential recall or withdrawal from the market, or a mere warning. Should the producer or other relevant party not be co-operative, or should the regulator view other measures to be more effective, the regulator can order remedies such as a recall as well.
Lastly, for certain product safety violations, the regulator can issue administrative fines or, if the violations amount to a criminal offence, involve the public prosecutor.
When making a product available on the market, the producer, its authorised representative and the importer are required to carry out sample-testing, investigate complaints and (if necessary) keep a register of complaints, as well as to inform the distributors of further measures related to the consumer product in question. The type of sample testing to be carried out depends on the risk level related to the products and on the possibility of preventing the risk. In any event, the producer’s obligations do not end once the product has been placed on the market; potential risks resulting from the use of the product also have to be monitored.
Upon discovery of a defect the producer, its authorised representative and the importer are required to take the steps necessary to remove or mitigate any unacceptable risk. The most hazardous products may even be subject to product recall. However, this will also depend on the severity of the risks posed by the defective product. Though producers may be under an obligation to take appropriate steps to mitigate a risk, which particular steps have to be taken depend on the specific product and the specific risk.
For example, products that are inherently more dangerous than others, such as medicinal products, operate under a stricter product safety regime. Additionally, it is now accepted that for products sold only to business users, a product can be recalled by issuing appropriate warnings to discontinue the use of the product, without a replacement product having to be offered (outside any contractual warranties). In the case of consumer products, the situation is not as clear and will depend on an individual assessment of whether the producer, its authorised representative or the importer can actually rely on the assumption that the consumer will discontinue use of the defective product, even if the consumer does not receive a replacement.
Trigger for Notification
Under the PSA (and the new MSA), the producer, its authorised representative and the importer are required to immediately inform the competent market surveillance authority if a product made available by them presents a risk to health and safety. This means that the trigger is actually risk-based and notification to the authorities can be required even if an incident has not yet happened. Information contained in this notification must at least cover:
This regulatory reporting obligation presupposes that the producer, its authorised representative or the importer knows or, on the basis of the information available or their relevant experience, must know that the product in question poses a risk. Clear indications are therefore not necessary to trigger the obligation.
Time Limits
“Immediately” means without undue delay. This legal term is not strictly defined under German law and must be determined on a case-by-case basis, depending on the level of risk arising from the product in question and other specifics of the case. Some (albeit non-binding) guidelines can be found in the Commission Decision of 14 December 2004 (2004/905/EC). Under these guidelines, the report must be made “without delay, as soon as the relevant information has become available, and in any case within 10 days since [the manufacturer or importer, etc] has reportable information indicating the existence of a dangerous product. When there is a serious risk, companies are required to inform the authority immediately and in no case later than three days after they have obtained notifiable information. In an emergency situation, such as when immediate action is taken by a company, the company should inform the authorities immediately and by the fastest means. [...] However, no company should delay a notification because part of the information is not yet available”.
Formal Requirements
The formal requirements are relatively limited. There are no prescribed forms that must be used. Most importantly, notification can be given electronically. In particular if a report has to be submitted in several member states of the European Union, the Product Safety Business Alert Gateway hosted by the European Commission can be used. This application form has the advantage that every competent authority in the affected member states will be notified simultaneously. Apart from that, a template form for the notification of dangerous products to the authorities by producers or distributors can also be found as Annex I to the Commission Decision of 14 December 2004 (2004/905/EC).
The authorities can demand a power of attorney (PoA). However, it is possible to initiate the notification even if a written PoA is not yet available.
The PSA provides for administrative fines and even criminal sanctions. For most violations of the PSA the administrative fine is kept at EUR10,000. However, for certain more severe violations the administrative fine can reach up to EUR100,000 and, in the case of intentional violations of certain of its provisions, the PSA even contains criminal offences which provide for imprisonment of up to one year or criminal fines. Notably, if a person is harmed by a product which should have been recalled but either has not been recalled, or was not recalled soon enough, criminal sanctions under general criminal law may apply as well.
German law does not recognise corporate criminal liability, which means that sanctions will be issued to individuals.
Apart from the above-mentioned administrative fines and criminal sanctions, the German general law on administrative fines provides for the skimming of profits, which may lead to the consequence that any revenue generated by the sale of non-marketable products must be paid back to the relevant authorities. This sanction may be issued to the relevant corporate entity and may be much higher than the respective fine.
Sanctions in the form of administrative fines under the PSA or other relevant product safety laws occur quite frequently. Usually, in particular in the case of a first violation by the responsible person, the amount of the fine will be rather limited. Criminal proceedings based upon violations of product safety laws are rare in Germany.
The Product Liability Act
In Germany, both the Product Liability Act (PLA or Produkthaftungsgesetz) and tort law govern product liability. In addition, there is specific legislation with regard to certain products; such as the Medicinal Products Act, which governs liability for pharmaceuticals.
Liability under the PLA presupposes that a defective product causes a person’s death, bodily harm, damage to health or damage to property. Liability for damage to property, however, only applies if the respective damage was caused to property other than the defective product or property ordinarily intended for private use or consumption.
The causes for actions due to product liability vary. German law differentiates between manufacturing defects, construction defects, instruction defects and monitoring defects. In some cases, the producer may also be liable for an ineffective product or suspected defects.
The claimant bears the burden of proving the existence of a defect, the damage caused and the causal relationship between them. The producer may defend itself by referring to the technical and scientific knowledge that was available at the time when it made the product available to the market.
Tort
Under tort law, the claimant bears the same burden of proof. If successful, however, the burden of proof shifts and the producer must then refute the presumption that it acted negligently (in other words failed to fulfil its duty of care). In addition, unlike under the PLA, damage caused where the product was primarily used for business purposes can be recovered.
Anyone who suffers damage due to a defective product is entitled to bring a claim under both the PLA and tort law.
Unlike other jurisdictions, German law, in principle, provides for consumer associations to raise claims due to product liability only under limited circumstances. There has been, however, since 2018, the possibility of implementing the so-called model declaratory action (Musterfeststellungsklage, see 2.16 Existence of Class Actions, Representative Proceedings or Co-ordinated Proceedings in Product Liability Claims). The model declaratory action is a (purely) civil procedure law tool providing a new form of collective redress in Germany to strengthen consumer protection. However, it does not create any substantive rights or claims for consumers.
Any model declaratory action under German law will be dealt with by the appeal-level courts as courts of first instance. Only one further appeal directly to the German Federal Court is possible. However, at the end of such a proceeding there will be a declaratory judgment stating whether a producer may be liable for a product defect (or any other subject raised in the model declaratory action). This judgment will be binding for the defendant and for the registered claimants only (ie, it will not be binding for any other parties not involved). It can therefore be regarded as an opt-in model. After the declaratory judgment, the individual registered claimants will still have to file a claim for quantum against the defendant.
So far, 28 cases for a model declaratory action have been filed. Judgments have already been obtained in ten cases. However, it is not yet possible to make a valid assessment, as six of the cases are currently before the Federal Court of Justice on appeal. In two other cases, the Federal Court of Justice ruled against the plaintiffs, once on substantive grounds and once rejecting the association’s standing to sue due to the insufficient number of members. Also, in the first instance, a couple of cases have been rejected as inadmissible due to the lack of standing of the consumer association that filed the complaint. The first and best-known model declaratory action in Germany, against Volkswagen AG, ended with an out-of-court settlement in which more than 240,000 consumers received a compensation payment totalling more than EUR750 million from VW. In the absence of previous model declaratory judgments, no subsequent claims by individual registered claimants for quantum regarding specific (compensation) payments are pending.
Claims under the PLA become statute-barred within three years of the day on which the party entitled to damages became aware, or should reasonably have become aware, of the damage, the defect and the identity of the party liable to pay damages. The limitation period shall be suspended if negotiations are pending between the party liable for damages and the party entitled to damages concerning the damages to be paid, until such time as one of the parties refuses to continue the negotiations. In addition, there is a preclusion period. Claims under the PLA expire within ten years of the time when the producer made the product available on the market. This preclusion period does not apply if a legal dispute or dunning procedure is pending over the claim or if the claim has been legally established, if it follows from another enforcement order, if it is the subject of an extrajudicial settlement or if it has been acknowledged through a legal declaration.
Claims under tort law also become statute-barred within three years. The limitation period commences at the end of the year in which the claimant knew or should have known of the damage, the defect and the identity of the potential defendant. Here, too, legal proceedings or negotiations between the parties concerning the claim suspend the course of the limitation period.
There are different long-stop dates depending on the type of claim. A claim for bodily injury has a long-stop date of 30 years and a claim for property damage either becomes statute-barred within ten years of the damaging event or within 30 years after the product was made available, whichever is earlier.
As a matter of course, actions due to product liability before German courts presuppose that German courts are competent. If that is the case, there are two potential types of jurisdiction. Firstly, there will always be jurisdiction at the seat of the defendant. Secondly, according to Section 32 of the German Code of Civil Procedure (ZPO or Zivilprozessordnung), there is jurisdiction under tort law. This provision is applied for claims under the PLA as well. The relevant places under this provision are the place where the tort occurred as well as the place where the actual damage occurred. For example, this may be the seat of the producer that has omitted to initiate a recall or, if a consumer is hurt at their home, the home of the consumer as well. As a practical matter, consumers will often try to bring cases in their “home” jurisdiction.
In general, there is no requirement for pre-action procedures in German product liability law. However, according to the Introductory Act to the Code of Civil Procedure, in some German federal states the claimant is obliged to conduct a pre-trial dispute resolution procedure when claiming less than EUR750.
It is customary for a claimant to send a demand letter before initiating a court proceeding. However, failing to do so will only have negative consequences with regard to the obligation to bear the costs of proceedings if the defendant recognises the case immediately after a complaint has been filed and served.
German product liability law does not provide any particular rules for preservation of evidence. However, from a product safety perspective, any steps taken to remedy a potential risk need to be recorded. In a civil proceeding in a product liability case it is certainly also advisable to be able to demonstrate compliance with product safety provisions.
There are no particular requirements for the treatment of an already recalled product, as long as it is safely stored and does not pose any further risk to consumers. The producer, its authorised representative or the importer is therefore free to either destroy or keep the recalled products at its own discretion.
It is, however, advisable to keep sufficient quantities of product samples of all variations of the recalled product. Such product samples will, for example, be required in the context of a risk assessment which the alerted market surveillance authority will most likely conduct at some point. In addition, product samples may be required for evidentiary purposes in a potential action for damages by harmed consumers.
Furthermore, the authorities might – at least where the product in question poses a “serious risk” – order the destruction of products where they deem this necessary and proportionate (see Articles 19(2), 29(4) of Regulation 765/2008/EC and Section 26 (2) sentence 2 No 8 of the PSA).
Depending on the individual case, it might make sense to come to an agreement with the authority on reporting obligations concerning the progress of the particular recall.
Lastly, depending on the relevant product, there are general requirements for the disposal (and destruction) of batteries, with which any manufacturer must comply (eg, under the German Battery Act or Batteriegesetz). However, these requirements apply to all batteries, not just those that are subject to a recall.
In cases of product liability, as in German civil procedure law in general, the parties are responsible for submitting those documents to the court that they wish to rely upon as evidence (the so-called Beibringungsgrundsatz). They do not have to submit documents that may be harmful to their case, but there is a duty of truthfulness. False statements to the court may therefore constitute a criminal offence. This may also include the deliberate failure to produce, or the incomplete production of, documents if this leads to inaccurate reproduction of the facts.
Under very narrow conditions, the law provides for exceptions to the general Beibringungsgrundsatz. A party may demand that the other party disclose certain documents according to Section 421 of the ZPO but the demanding party will have to identify the respective documents and explain why they require disclosure. Also, there is a claim for information according to the Medicinal Products Act (AMG or Arzneimittelgesetz), Section 84a of which allows the claimant to request disclosure from a pharmaceutical entrepreneur in relation to known and suspected adverse reactions and interactions.
In addition, the court may order a party to produce records or documents, as well as any other material, that are in their possession and to which one of the parties has made reference, according to Section 142 of the ZPO. However, German courts are very reluctant to follow a request according to Section 421 of the ZPO or to issue an order pursuant to Section 142 of the ZPO.
The rules with regard to expert evidence in product liability cases do not differ from the rules in civil procedure cases in general, which are laid down in Section 404 et seq of the ZPO. In their written submissions, the parties will state the facts they wish to rely on as well as the kind of evidence they suggest that the court consider.
The role of the party-appointed expert does not exist under German law. If a party suggests presenting evidence by way of an expert opinion, the court will appoint such an expert and can choose the person at its own discretion. However, before the appointment, the court generally hears the parties’ views on the proposed expert. In the case of a mutual agreement between the parties to the dispute regarding the person to be appointed as expert, the court will comply with what they have agreed; however, the court may limit the selection made by the parties to a certain number.
Expert Rejection and Disqualification
An expert may be rejected for the same reasons for which a party is entitled to challenge a judge. This means that they can be recused from the case where they are disqualified by law from exercising their duty and in those cases in which there is a fear of bias.
Reasons for an expert’s disqualification by law are:
For fear of bias the party must present sound reasons that justify a lack of confidence in the expert’s impartiality. This can be a personal or professional relationship to one party, former appointment in the same or a similar case or the concrete behaviour of the expert, any or all of which may give rise to concerns.
Aside from these mandatory reasons for disqualification as an expert, the parties can also challenge the professional expertise of an expert suggested by the court. If there are valid reasons, German courts often reconsider their proposal and appoint a different, more qualified expert.
Procedure
After giving their written opinion, the expert can then be requested to attend an oral hearing and can be questioned by both the court and the parties.
Apart from this, the parties may also submit their own expert’s opinion (ie, that of an expert not assigned by the court). However, these reports are only treated as party submissions, not expert evidence.
Both under the PLA and under tort law the claimant bears the burden of proof. As a result, they have to provide proof of the defect, the damage and the causal relationship between them. They must prove this to the satisfaction of the court. Under German civil procedure law, the standard of proof is “beyond reasonable doubt”. Prima facie evidence may suffice if the damage represents a typical result of the defect. The producer may, however, then prove a possible alternative cause for the damage.
The producer has to provide proof for any defences it claims under both the PLA and tort law.
Liability under tort law is fault-based and requires a negligent breach of a duty of care. Typically, the producer has to prove that they complied with their duty of care, proving – eg, that their production process, including quality control processes – complied with the state of the art processes at the relevant time.
As German law does not provide for any discovery, proving a case can be difficult for a claimant – in particular when facts relating to things that have happened within the sphere of the producer, such as the question of when a recall should have been initiated, are highly relevant. In such circumstances German courts may require the producer, though it does not bear the burden of proof, to submit relevant facts and evidence (sekundäre Darlegungslast), or may even shift the burden of proof.
Product liability cases are brought before civil courts. There is no special jurisdiction for such cases, neither do any specific procedural requirements exist. Up to a value in dispute of EUR5,000, district courts (Amtsgericht) are competent in the first instance. Above this threshold regional courts (Landgericht) are competent.
In the first instance, usually a single judge will preside over the case. Particularly in more complex cases, a panel of three judges may hear the case. Panels, however, only exist at regional courts.
In certain commercial disputes, the case may be transferred to a special chamber consisting of two non-professional judges with a professional commercial background and one legally trained judge.
Juries, however, do not exist in Germany.
Under the PLA there is an upper threshold for damages caused by bodily harm of EUR85 million as a maximum amount of liability for all cases caused by product. However, if the claim is based upon tort law, no limitation applies at all.
There are no specific rules in respect of product liability cases with regard to applicable rules for appeal. Under German procedural law (Section 511 et seq of the ZPO, Berufung), appeals are an available remedy against final judgments delivered by the courts of first instance. Appeals, however, are only admissible if the value of the dispute exceeds EUR600 or if, in its ruling, the court of first instance grants leave to appeal.
The court of first instance shall admit an appeal in cases:
The time limit for filing an appeal with the court of appeal is one month. This is a statutory period which begins once the fully worded ruling has been served, and at the latest upon the expiry of five months following pronouncement of the judgment. The notice of appeal must, as a minimum requirement, set out the reference number and designation of the judgment against which the appeal is being lodged and the declaration of the appeal being filed against the judgment. Usually the appellant also submits a certified copy of the judgment being challenged together with the notice of appeal. The particulars of the appeal must be submitted within one further month, ie, within two months from when the fully worded ruling has been served. However, the judge may extend this period by up to one further month.
After the appeal, there is only one further appeal possible to the German Federal Court. This second appeal can only be based upon legal grounds and not misinterpretation of factual issues. It can only be brought if the appeal court has allowed it or the German Federal Court has accepted it.
PLA
Under the PLA, the producer may raise the following defences:
The producer of a component of the product will not be liable if they prove the defect can be attributed to the instructions given by the manufacturer or the design of the product.
Tort
Under tort law, the defences are very similar. Other potential defences to a producer’s alleged negligence also include that:
Compliance with regulatory requirements does not generally constitute a defence as such for the producer. However, these requirements can usually be considered in order to determine the level of legitimate safety expectation, the relevant state of the art processes and the applicable standard of care to be applied.
The prevailing party is entitled to recover its costs, including its attorney’s fees, from the losing party.
The amount of the claim for reimbursement of costs is dependent on the extent to which the prevailing party prevails in relation to the underlying defeat of the other party.
In Germany, the minimum attorney’s fees are regulated in the Lawyers’ Compensation Act (Rechtsanwaltsvergütungsgesetz) and depend on the amount in dispute. Even if the client and the attorney agree on hourly fees, the prevailing party’s claim for reimbursement is limited to the statutory fees. The statutory fees include rates for the conduct of litigation and the conduct of the court hearing. Additional fees are charged for particularly extensive taking of evidence or in the event of a settlement agreement. In addition, expenses such as travel expenses, translation costs, etc, are also taken into account in the reimbursement claim. Furthermore, advance payment of the court fees, which must be made by the claimant, is proportionally recoverable to the extent the claimant prevails. The same applies to any advanced payments for witnesses or experts.
Even if the costs of litigation are fairly moderate compared to some other jurisdictions, more than 40% of all German households have legal protection insurance in place, ie, insurance policies with private insurance carriers covering legal costs and expenses associated with enforcing or defending legal claims both in and out of court. These policies play an important role in consumer litigation as they practically annihilate the “loser pays” rule and allow policyholders to bring legal action without a cost risk.
In addition, legal aid is available in certain circumstances and is particularly common in consumer cases. A court will grant legal aid only if it is satisfied that the potential claim or defence has reasonable merits and that the party seeking legal aid meets the financial criteria of indigence. If granted, legal aid covers attorneys’ fees and court fees, including the fees of any court-appointed experts and other necessary expenses. There is no legal remedy available to the opponent to contest the grant of legal aid.
In addition, third-party litigation funding is permissible in Germany. While third-party funding has been available in Germany for several years, it used to only play a role in commercial litigation. Recently, however, litigation funders have begun to fund consumer claims and product liability claims in particular as test cases for potential mass litigation.
Conditional or contingency fees are not permissible in Germany. The same applies to success fees, with a very narrow exception for cases in which the client would otherwise not be able to fund the proceedings.
Generally, German civil procedure does not permit class or group actions seen in other jurisdictions.
With effect from November 2018, however, the system of the so-called model declaratory action (Musterfeststellungsklage) has been introduced into the German Civil Procedure Act. Consumer advocates consider it a milestone for consumer protection. This new type of representative proceeding enables certified consumer associations to seek declaratory findings on questions of fact that may be relevant for the subsequent determination of a multitude of consumer claims, and which become binding upon those consumers who opt-in to the proceedings by registering their individual claim in a public claims register before the first court hearing. The litigation is run by the consumer association, whereas the registered consumer does not become a party to the proceedings. Registration in the claims register, however, suspends limitations of the consumer claims registered.
Strict requirements apply concerning the size and standing of the consumer associations, in order to avoid plaintiffs’ law firms or litigation funding companies setting up such institutions as a vehicle to pursue commercial interests. Among others, the consumer associates must operate on a non-profit basis, have at least 350 members and have been in existence for at least four years by the time the action is filed. Upon filing the action, the consumer association must show that the subject matter of the action affects the claims of at least ten consumers. Also, at least 50 consumers must have registered their claims in the claims register within two months following publication of the action.
The model declaratory action aims at the determination of (i) factual and legal preconditions for the existence of a consumer claim (eg, whether a certain product suffered from a product defect), or (ii) the existence or non-existence of a legal relationship between a customer and a producer (eg, whether consumers of a certain product can request that the producer supply a replacement product).
The model proceeding can end with a settlement between the consumer association and the defendant producer or by a declaratory model decision. The decision is binding on all consumers who registered their claims up to one day before the first court hearing. The consumers must pursue their individual claims against the producer in a separate and ordinary court proceeding, eg, to prove causation and damages in their individual cases. The court ruling on the individual claim will, however, then be bound by the decision in the model declaratory action, eg, that a certain property of the product used constituted a product defect.
Please refer to 2.2 Standing to Bring Product Liability Claims for further discussion of the model declaratory action and the status of relevant developments and procedures.
Diesel Litigation
Over the past five years, German civil courts have been very busy dealing with consumer claims in the so-called diesel emissions scandal Several thousand German consumers have filed individual claims against their car dealers (claims under contract) and/or against several German car manufacturers (claims in tort). To date, many courts, including several Higher Regional Courts, have rendered judgments on these claims. In February 2019, the German Federal Court dealt with a claim against a car dealer and determined that the emission control software used constituted a defect under the sales contracts so that the buyer is generally entitled to request delivery of a replacement car. The court held that depending on the circumstances of the individual case, such claims may even extend to the supply of a new car of the current production series, if the model of the car that was bought has run out of production. In May 2020, the German Federal Court ruled that a buyer of a manipulated Volkswagen diesel car was entitled to damages against Volkswagen (VW). VW must pay damages for immoral intentional harm and refund the purchase price against return of the car. However, the buyer must take into account the benefit of the previous use of the car for the kilometres so far driven in it. In addition, the Federal Court ruled in July 2020 that in cases where the purchase of the vehicle took place after the diesel scandal became known in September 2015, immoral intentional damage is to be denied. In the near future, a decrease in the courts’ involvement in these diesel cases is to be expected, as claims by possible injured parties who have not yet filed suit are now time-barred.
Removal of the RAPEX Notification in Cases of Incorrect Risk Assessment
In 2019, the Muenster Administrative Court ruled that the manufacturers of a wrongly notified product can force the removal of the RAPEX notification if the notification was based on an incorrect risk assessment (Muenster Administrative Court, judgment of 13 November 2019, docket 9 K 2514/16). The Rapid Exchange of Information System (RAPEX) is the European Union’s rapid alert system for dangerous consumer products, excluding food, medicines and medical devices. Under the RAPEX system, national market surveillance authorities notify information on dangerous products to the European Commission if they are considered to pose a serious risk under the PSA and require a recall of the products. On a weekly basis, the Commission publishes a list of the notified products, to warn consumers of their dangers. However, it often happened that the notified products did not actually constitute a risk and the RAPEX warnings were inaccurate. This caused great damage to manufacturers.
A manufacturer of erasers, which were declared as toys for children over the age of three, brought an action before the Muenster Administrative Court. The Court ruled that the market surveillance authority that initiated the notification of the product to the list is responsible for its removal. The manufacturer or importer is entitled to have the authority request the Commission to remove the RAPEX warnings posted on the Commission’s website if the notification was based on an incorrect risk assessment.
Product Liability in the Digital Age
At the beginning of 2020, the Internal Market and Consumer Protection (IMCO) Committee of the European Parliament held an expert consultation on the revision of the Product Liability Directive 85/374/EEC and adapting it to the digital age, which was followed by another report on product liability in the digital age. In this context, the need for revision or new regulation of the following aspects were, in particular, pointed out.
The consultation was closed on 10 January 2022. A summary of the consultation results shows that views differ on the need to revise the Product Liability Directive. In particular, the introduction of a possible reversal of the burden of proof in favour of consumers, the consideration of immaterial damages, the clarification of the term “product” and the development of separate liability rules for high-risk AI systems are in dispute. Adoption by the Commission is currently planned for the third quarter of 2022.
Mass Litigation
Much more so than through any modifications of substantive product safety and liability laws, the German product liability landscape has recently undergone significant changes as a result of the mass litigation concerning the so-called diesel emissions scandal. Several formerly small and mostly local plaintiff law firms have systematically engaged in this litigation by building up human and technical resources to bring individual claims against the manufacturers and their dealers on behalf of hundreds and in some cases thousands of consumers. This goes along with broad client advertising campaigns involving radio, TV and social media, previously unknown in Germany. One must expect that as the end of the diesel emissions litigation approaches, the plaintiffs’ law firms will seek to employ the skills and the new resources developed in this period to target other products and other companies and that product liability litigation will consequently play a bigger role in Germany than in the past.
The effects of the 2018-introduced model declaratory action (Musterfeststellungsklage) – for more on which refer to 2.16 Existence of Class Actions, Representative Proceedings or Co-ordinated Proceedings in Product Liability Claims – will also be of particular interest. The first model declaratory action filed by the Federal Consumer Association against Volkswagen did not end with a court ruling, but with a settlement. More than 240,000 consumers affected by the diesel emissions scandal – who had bought a car by 31 December 2015 and registered their claims in the claims registry – received a refund of 15% of the original purchase price, as long as they agreed to the settlement. Apart from this, it remains to be seen whether this new form of collective redress can be handled from a procedural perspective and whether it can contribute to resolving or dismissing claims efficiently.
In addition, the already mentioned recent interest of litigation funders in mass proceedings in the German market – see 2.15 Available Funding in Product Liability Claims – will make it much more likely for consumer claims to be brought.
The EU Representative Action
While the German legislature has only recently introduced the model declaratory action as a collective redress mechanism (see 2.16 Existence of Class Actions, Representative Proceedings or Co-ordinated Proceedings in Product Liability Claims and 3.1 Trends in Product Liability and Product Safety Policy), the European Commission has been contemplating the introduction of further-reaching collective redress mechanisms across all member states as part of the so-called REFIT process of the consumer law acquis.
In November 2020, the European Parliament adopted the Directive introducing the European representative action (Directive (EU) 2020/1828) in accordance with the European Commission’s proposal. The Directive sets a binding framework for representative actions for the member states. Essentially, the Representative Actions Directive provides that qualified entities can bring actions against traders who breach EU consumer protection rules, with the aim of obtaining injunctive or remedial relief such as damages, repair or termination of contract. In addition to general consumer law, the Directive directly affects the field of product liability, among others.
Due to the implementation period for member states, it is to be expected that the representative action will be introduced in Germany by the end of 2022 at the latest and will come into force no later than mid-2023. Since this representative action will have to go further than the model declaratory action introduced in 2018, discussion about collective legal protection in Germany will probably be stimulated in the near future. However, it is clear that the EU Commission will continue to consider product liability litigation as a means of public enforcement of product safety rules and standards. Issues of civil procedure law and litigation mechanisms will thus likely remain on the agenda of EU lawmakers, including as part of the EU’s product safety policy.
EU Product Safety Regulation
On 30 June 2021, the European Commission made a proposal for a General Product Safety Regulation (the “Product Safety Regulation”) to revise the outdated Product Safety Directive. The new proposed Product Safety Regulation will replace the Product Safety Directive. The Product Safety Regulation will introduce new product safety regulations for online markets. Products are already considered “made available on the market” when they are offered on shopping platforms and can be prosecuted by market surveillance. Another essential element of the Product Safety Regulation is the way it function as a safety net by defining the market surveillance rules for non-harmonised products (eg, furniture, childcare articles or textiles) and adapting them to products falling within the scope of harmonisation rules (the so-called harmonised products; eg, electronic devices or medical devices), which are defined in Regulation (EU) 2019/1020 (the “Market Surveillance Regulation”). The same market surveillance rules apply to all products. According to the EU Commission, the draft is still being negotiated in the trilogue (Council, EU Parliament, EU Commission). There is no time schedule, so it is not currently foreseeable when the EU Product Safety Regulation will be adopted and enter into force. The regulation will be directly applicable in the member states and will make large parts of the German PSA redundant.
New Machinery Regulation
Additionally, the European Commission published a proposal for a new Machinery Regulation on 21 April 2021. Directive 2006/42/EC (the “Machinery Directive”) is to be updated to further increase the level of safety and to take into account the latest IT innovations in areas such as digitalisation, artificial intelligence and collaborative robotics. The Machinery Regulation now proposed is intended to resolve inconsistencies with other EU product regulations and close existing regulatory gaps in the current Machinery Directive. Publication of the Machinery Regulation is planned for 2022, with a transition period of 30 months during which the Machinery Regulation will not have to be applied.
Regulation Laying Down Harmonised Rules for Artificial Intelligence
On 21 April 2021, the EU Commission proposed a regulation establishing harmonised rules for artificial intelligence (the “Artificial Intelligence Directive”). The proposed AI Regulation primarily places obligations on providers of AI systems for the placing on the market, commissioning and use of artificial intelligence systems. The regulation takes a risk-based approach and is intended to reconcile innovation and high ethical standards in the future. A total of four risk classes (unacceptable, high, low and minimal risk) are envisaged. The measures range from minimum requirements that must be met by providers and users of the systems to bans on AI systems that violate fundamental EU values. AI systems with a low or minimal risk are not subject to regulation, but providers of such systems can voluntarily follow codes of conduct. The AI Regulation shall apply two years after its entry into force.
Toys Directive
The EU Commission is preparing a revision of Directive 2009/48/EC (the “Toys Directive”). In February 2022, the EU Parliament voted in favour of stricter safety requirements for all toys sold in the EU. The Parliament sees dangers to children’s privacy and mental health in networked toys in particular. In addition, the EU Parliament is in favour of an import ban on toys containing certain chemicals, such as “endocrine disruptors.” Adoption by the EU Commission is planned for the fourth quarter of 2022.
Construction Products Regulation
On 30 March 2022, the EU Commission also presented a proposal for the revision of the Construction Products Regulation. This is intended to pursue the following objectives:
The Council and the EU Parliament must now take a position on the proposal before negotiations on a final version can begin.
With regard to product safety law and products that are afflicted with notifiable pathogens or if this can be assumed and a spread of the disease is to be feared as a result, the German Infection Protection Act (IfSG or Infektionsschutzgesetz) provides for special powers of action for the authorities to avert imminent dangers. These can be decontamination measures (such as disinfection), quarantine measures or even destruction. As lex specialis, the Infection Protection Act is applicable and has priority over the regulations of the PSA. The IfSG was adapted to the current situation with effect from 20 March 2022, as most of the coronavirus-protection measures that had their legal basis in it were limited in time until 19 March 2022.
Court Response
Since the outbreak of the COVID-19 pandemic in Germany, the authorities and courts in Germany have taken security measures to prevent rapid spreading of the virus. In particular, distance and hygiene regulations and the obligation to wear a mouth and nose mask have had to be observed. More recently, the coronavirus rules have largely been eliminated. However, stricter regulations may apply on a local basis. Individual states are responsible for the concrete implementation of health precautions.
Court hearings are mostly being held in person again; however, it is possible to hold hearings by video conference, if necessary. If there is no longer an official mask requirement, the judge may order the wearing of masks during the trial. Attention continues to be paid to maintaining minimum distances.
Specific Areas of Regulation
So far, there are no specific areas targeted by the authorities for special exemptions or policies to respond to the crisis with regard to product safety or liability issues.
The retail trade in particular, but also service providers, are subject to special regulations to minimise infection, which are decided at the state level. For example, in many federal states (which can largely implement the federal requirements at their own discretion) retailers must monitor that their customers are wearing a protective mask when entering a shop, although access restrictions have been lifted. Depending on the federal state, the fine for violating the mask requirement is between EUR50 and EUR500.
Supply Chain Management
In general, according to surveys, many German companies have implemented immediate measures in the areas of liquidity increases, cost reduction and supply chain stabilisation. Measures to ensure liquidity include – in particular – the adjustment of working capital, scenario-based planning and the reduction of currently non-critical expenses. The main measures taken to stabilise the supply chain and make it more resilient include the introduction of alternative supply scenarios and the establishment of a central “War Room” where information on the coronavirus pandemic is gathered and from where further decisions are initiated.
Future Impact
In the beginning of the pandemic, a supplier that was unable to supply its customers due to officially ordered quarantine measures or closures, or whose employees could not carry out their work due to quarantine or lockdown orders, might be exempted from its obligation to perform during this period under German law. In particular, this applies to contractual exemption clauses in cases of force majeure, which in most cases will include pandemic conditions. However, at this stage, the pandemic is more likely to no longer be considered an unforeseen event and therefore no longer falls under a force majeure exemption. In this respect, it is of major importance that the principal is able to provide alternative service.
Hanseatic Trade Center
Am Sandtorkai 41
20457 Hamburg
Germany
+49 40 36803 0
+49 40 36803 280
P.Behrendt@taylorwessing.com www.taylorwessing.com2021: a Year of Change in German and European Product Liability Law
In terms of product safety, 2021 was a remarkable year. Important EU Regulations, such as EU Regulation 2019/1020 on market surveillance and compliance of products (the “Marktüberwachungs-Verordnung”), which provides numerous stipulations of great relevance and grants regulators a broader approach, came into force. Furthermore, EU Regulation 2017/745 on medical devices (the “Medizinprodukte-Verordnung”) came into force on 26 May 2021.
The courts have also contributed to the development of product liability law in 2021, and attention should be paid not only to the consequences of a decision of the Higher Regional Court Frankfurt a.M. of 24 June 2021 (6 U 244/19) but to other court decisions mentioned below which brilliantly demonstrate the multifaced nature of product liability and safety law. Last but not least, 2021 saw the emergence of some big time product liability issues on the horizon.
Operators of online marketplaces and their duties concerning product safety
The operator of an online marketplace must immediately block offers for a certain product if it has been notified of clear violations of the law (the “notice and take down” principle).
The Higher Regional Court Frankfurt a.M. had to rule on swimming discs offered via an online marketplace. The swimming discs in question are personal protective equipment within the meaning of Article 3 paragraph 1 (a) of EU Regulation 2016/425 on personal protective equipment and a consumer product within the meaning of Section 2 No 26 of the German Product Safety Act (the “Produktsicherheitsgesetz” – ProdSG aF; now Section 2 No 25, ProdSG). Such personal protective equipment is manufactured to be worn by a person as protection against one or more risks to their health or safety. The swimming discs obviously serve to ensure the safety of non-swimmers when bathing. The offered swimming discs neither had a CE marking nor a manufacturer’s label on them, and neither was an EU declaration of conformity attached.
According to the Higher Regional Court Frankfurt a.M. the operator of an online marketplace is subject to extensive legal obligations concerning product safety: not only is the operator obliged to take offers down, but must also take precautions to prevent further infringements by the offending distributor’s account, if possible. The operator of the online marketplace – at least in the case of a violation of product safety regulations – has the obligation to prevent such violations in the future, which can be enforced by injunctive relief. The reason for such a wide obligation is that blocking the offer in question does not solve the problem once and for all, since traders may place the same offer again immediately after the original offer was deleted. Therefore, the operator of an online marketplace must additionally ensure that there will be no further violations caused by the offending account.
This obligation is imposed on the operator due to their risk-increasing conduct, which is based on the provision of the online marketplace. However, this obligation is subject to the condition that significant consumer interests must be affected. This was the case here because of the necessity of protecting customers or third persons. The obligation is further limited by the fact that lack of conformity of the products concerned must be easily recognisable. This might be the case for a missing manufacturer’s or CE marking. This should not be the case, however, where an EU declaration of conformity is missing or where it is questionable whether the markings are materially correct.
The Court held that the operator’s duty merely applies to traders where there are indications of earlier infringements due to previous complaints, and upon the condition that the new offer is almost identical to the previous one that was subject to objection.
Food or non-food: that is the question
Hamlet would have asked “food or non-food” when thinking about nicopods. Numerous German courts had to deal with similar issues.
Nicotine pouches, so called nicopods, are small white pouches for oral use containing natural fibres with nicotine and without tobacco. They are placed between the upper lip and the gums or in the cheek pocket and left there for some time while nicotine and flavours are released. The nicotine is essentially absorbed through the oral mucosa. The nicotine pouch is not chewed or swallowed, but removed and disposed of after use. The product presentation is similar to that of chewing tobacco, snuff or snus and contains various warnings, in particular about the highly addictive effect of nicotine, acute health hazards in case of unintended swallowing and that it is only available to persons over 18 years of age. Most products also carry a red warning symbol with an exclamation mark.
The courts had to deal with the question of how food law and product safety law are to be distinguished from each other. Insofar as nicopods are classified as food, general rules of product safety do not apply. According to Article 2 paragraph 1 of Regulation (EU) 178/2002 laying down the general principles and requirements of European food law, establishing the European Food Safety Authority and laying down procedures in matters of food safety (the “Lebensmittel-Basis-Verordnung”), any substance or product, whether processed, partially processed or unprocessed, intended to be, or reasonably expected to be ingested by humans is considered food. Therefore, in the past, courts took the view that it was sufficient to considering nicopods to be food when nicotine was supplied to the human body through the mouth’s mucous membranes. It was not necessary to supply the substance specifically to the stomach; for example by consumption.
The Administrative Court in Munich is one of many courts that recently had to deal with the question of food or non-food (20 May 2021 – M 26b S 20.6309). The judges in charge showed their skills in applying all the different methods of interpretative criteria in order to determine whether the substances thus ingested fulfilled the concept of “human ingestion” within the meaning of Article 2 paragraph 1 of Regulation (EU) 178/2002.
Any interpretation of the law needs to begin with a certain provision’s wording, while at the same time the wording is the limit of interpretation. In the present case, the interpretation shows that the view held by the applicant that the concept of ingestion by humans is to be equated with the concept of consumption and necessarily presupposes an ingestion of substances into the gastrointestinal tract, does not do justice to the concept of food under Article 2 of Regulation (EU) 178/2002. This view is also supported by a systematic interpretation of the applicable law: Article 2 paragraph 1 of the Lebensmittel-Basis-Verordnung demands a broad scope of application. Accordingly, products that have been ingested but not consumed are not marketable if they are harmful to health.
Had the courts found that the scope of Regulation (EU) 178/2002 did not embrace these products from the outset, this important protective mechanism would no longer apply. The scope of application, which is understood broadly, is limited on the one hand by the requirement of intended human ingestion and on the other hand by the exclusion of certain substances and products from the concept of food. The exceptions listed in Article 2 Section 3 of Regulation (EU) 178/2002 exclude from the scope of application certain products which are ingested but not consumed in a strict sense; for example, cosmetic products that enter the body externally through the skin or tobacco products that are ingested orally (chewing tobacco) or through the respiratory tract. There would be no need for such exemptions if ingestion were to be equated with consumption. The fact that the scope of application is to be understood broadly is also supported by the meaning and purpose of the law; the fact that the German legislature in relevant provisions of the German Food and Feed Code (the “Lebensmittel- und Futtermittelgesetzbuch” – LFBG) speaks of “consuming” “through the stomach” is irrelevant due to the superseding application of EU law. However, the historical interpretation is not helpful because nicopods are novel products, which the Commission most probably did not have in mind when publishing the Green Paper on Food Law in 1997. Finally, the comparison with chewing gum speaks for the classification as food. The latter is explicitly designated as food even though chewing gum is also a carrier substance whose ingredients are mainly absorbed through the oral mucosa before the carrier substance is removed after use and not swallowed.
PFAS
At the beginning of this year, the European Chemicals Agency (ECHA) published a proposal to restrict so-called perfluorinated and polyfluorinated alkyl compounds (PFAS or PFT/PFC) in fire-fighting foams. PFASs are a group of more than 7,800 material components that have been used in industrial production since the 1930s. PFASs have a water and dirt-repellent effect, and PFAS components are commonly used in many products and industries. They are found in cable insulation, cleaners, clothing, coated cooking utensils, paper and paints, among other things.
PFAS are sometimes referred to as “forever chemicals” as they are not subject to any natural degradation process. Their use is therefore associated with incalculable risks in the long run. PFAS residues can be found almost everywhere in the atmosphere, soil and water. PFASs are also deposited in the human body and never completely degrade there as well.
Recent research shows that exposure to substances from the PFAS family (among others) can cause or at least aggravate increased cholesterol levels, changes in liver enzymes, reductions of birth weight in new-borns, thyroid disorders, reduced vaccination responses in children, not to speak of kidney and testicular cancer.
In the United States of America – where else? – there are already several large-volume class action lawsuits pending regarding PFAS-related health and environmental damage. In response to that, among other things, environmental regulations will come into force in many US states by the end of 2022, banning the use of PFAS in food packaging. In addition, PFAS limits have been set for drinking water. The European legislature has already adapted Directive (EU) 2020/2184 of 16 December 2020 while the German legislature has amended the Drinking Water Ordinance in this respect.
Due to the harmful effects of PFAS on health, product liability of manufacturers of products containing PFAS is quite conceivable. It is, of course, up to the potential claimants to demonstrate and prove a causal connection between products containing PFAS and possible health impairments. As in other cases in which plaintiffs claim to have suffered health damage due to environmental toxins or chemicals, a distinction from the general risk of disease and proof of causation are required above all. Claimants often cite the mere fact that they fear serious illness as an impairment of health in trial. So far, this argumentation of the claimants (eg, in “Valsartan” cases) has had little success with German courts. That view is convincing, and any other would entirely dilute the concept of health impairment as a requirement for damages.
Insofar as PFAS residues are found in the soil of a property, there is a threat of public law measures aimed at ensuring that such residues will be removed. According to the German Federal Soil Protection Act (BBodSchG), both polluters and property owners are obliged to ensure the removal of any PFAS contamination. Due to this liability situation, the insurance industry should discuss how the PFAS issue will need to be dealt with in terms of coverage.
A risk-limiting effect can be achieved via the serial damage clause, provided that its requirements are met regarding PFAS substances. Where PFAS structures are concerned, it is assumed they have a similar or identical mode of operation. However, PFASs are used in a variety of ways and in very different industries that have no connection to each other. Hence, regarding PFAS structures, the serial damage clause may only be triggered by the same cause. A further prerequisite for the serial damage clause to apply is that there is an “internal connection”. In the case of damage resulting from the use of PFASs in different industries and end products, such internal connection is difficult to affirm. If, on the other hand, PFAS structures that were used in the same way are involved (eg, during the production of certain cosmetics or textiles) and a specific product is affected, then not only the “same cause”, but also the “internal connection” may well exist.
In addition, insurers will have to assess whether the risks associated with PFAS will be covered with significant restraint in the future. A look at the handling of asbestos, which is subject to comprehensive risk exclusions nowadays, shows how restrictively the insurance industry can act where the overall insurability of certain substances is concerned. The reaction then shows a parallel to the damages and compensation litigation already pending in the Anglosphere. Underwriting departments will have to look at incurred but not reported risks in quite some detail. The main problem for insurers, however, was that asbestos risks were not (or were no longer) reinsurable. The insurance industry could face the same problem with PFAS.
Ethylene oxide-related recalls
Recalls related to Ethylene Oxide (ETO) are about to become the biggest EU-wide recall scenario in 2022. ETO is a gas whose use as herbicide has been prohibited in the EU since 1991 as it was qualified as both carcinogenic and mutagenic. ETO is highly unstable, and its residues are thus defined as the sum of ETO and 2-chlorine ethanol (being the oxidation product).
2-chlorine ethanol has been detected in batches of locust bean gum (E410), guar gum as well as nutritive additives such as calcium carbonate throughout Europe, often resulting from imported goods; eg, from China or India, where ETO is commonly used. Hence, the issue is hitting the entire industry and market surveillance authorities are enforcing Europe-wide recalls while distributors object to the approach of calculating residues focusing on 2-chlorine ethanol and whether scientific data is sufficient in this respect.
There are deviating decisions of German Administrative courts in this respect. A first instance court decided (in summary procedures regarding the immediate enforceability of an administrative order) that a safety recall ordered by authorities was lawful. On the other hand, the Higher Administrative Court Munich (03 February 2022 – M 26a S 21.6633) ruled that while the possibility of health impairment due to food containing 2-chlorine ethanol was established, there were still some scientific uncertainties. While Article 7 of Regulation (EU) 178/2002 allowed for preliminary risk management measures in order to secure a high level of health protection, it does not justify final and indefinite measures, and that was all the more true when authorities had not visibly taken measures to gather the necessary scientific certainty.
Apart from these public law questions, food and ingredients containing ETO have been sold by pure traders and distributors throughout Europe and – usually – to other businesses. Hence, strict liability under the German Product Liability Act is inapplicable and all other potential claims (under German contract and tort law) are subject to negligence. It is hard to see any kind of negligence when pure traders and distributors were unable to detect any ETO contamination, but relied on covenants of manufacturers that the supplies in question had not been subject to any ETO exposure. It is another question of course whether claims under the United Nations Convention on Contracts for the International Sale of Goods (CISG) will be less difficult to raise, but while those are not subject to negligence, the obligation to inspect incoming goods and notify potential defects in due course pursuant to Articles 38 and 39 of the CISG will gain some importance.
Insurers of traders and distributors will face more and more claims over this year and in 2023, and there is a high risk that the better part of these claims will erode coverage limits, leading to the necessity of insurers having to prepare for allocation procedures in terms of Section 109 of the German Insurance Contract Act.
Theodor-Heuss-Ring 13-15
50668 Cologne
North Rhine-Westphalia
Germany
+49 221 944 027 911
+49 221 944027 7
koeln@bld.de www.bld.de